InvestorsHub Logo
Followers 259
Posts 3732
Boards Moderated 0
Alias Born 04/26/2013

Re: None

Thursday, 08/20/2015 7:20:27 PM

Thursday, August 20, 2015 7:20:27 PM

Post# of 5242
Real biotech companies have access to capital, not $31K in the bank. The company has IOUs and will have to dilute shareholders further next year.

They can talk about all their trials (that don't begin anytime soon) all they want, but they better start talking about how they are going to pay for them and how they will escape the taint of their large owner.

Our cash requirements for the next twelve months are $1,260,000.


If you don't like my posts, don't read them. If you think only those who agree with you should post, then start your own message board. My conclusions are my opinion only, based on what I believe to be true. I have no crystal ball.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News